Ascentage Pharma’s Novel Cancer Drug Approved in China
Monday, 14 July 2025 ()
In This Article: Ascentage Pharma Group International (NASDAQ:AAPG) is one of the best young stocks to buy and hold for 5 years. On July 10, Ascentage Pharma announced that China’s National Medical Products Administration/NMPA approved its novel Bcl-2 selective inhibitor, called lisaftoclax…
|
||||
You Might Like |
||||
